SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019713
Filing Date
2020-04-29
Accepted
2020-04-29 16:15:20
Documents
6
Period of Report
2020-06-11
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A mirm-def14a_20200611.htm DEF 14A 881681
2 GRAPHIC gtgrrdgrbyg5000004.jpg GRAPHIC 46139
3 GRAPHIC gtgrrdgrbyg5000005.jpg GRAPHIC 49367
4 GRAPHIC gtgrrdgrbyg5000003.jpg GRAPHIC 1931
5 GRAPHIC gtgrrdgrbyg5000001.jpg GRAPHIC 2593
6 GRAPHIC gtgrrdgrbyg5000002.jpg GRAPHIC 2197
  Complete submission text file 0001564590-20-019713.txt   1024224
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38981 | Film No.: 20830487
SIC: 2834 Pharmaceutical Preparations